UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Xylocain-100mgml-cutspray-SE-AJ-MPD-BBDL

Xylocain 100mg/ml Kutan spray, lösning

MPID: SE-100001718-00011258
EURDID: 10933

Full name: Xylocain 100mg/ml Kutan spray, lösning

- Invented Name Part: Xylocain

- Strength part: 100 mg/ml

- Pharmaceutical dose form part: Kutan spray, lösning

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Cutaneous spray, solution

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097196 lidocaine

Marketing Authorisation 1 of 1

Authorisation number: 11258

Region: Kingdom of Sweden

Marketing authorisation holder: Aspen Pharma Trading Limited

Identifier:

  • LOC-100001575

Status: Valid (1990-11-26)

Package 1 of 1

PCID:

Description:
Flaska med pumpspray, 50 ml

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 vial

Package: 1 Box (Cardboard)

Containing:

Package: 1 Spray pump (Plastic)

Containing:


Package: 1 Vial (Glass type I)

Containing: 50 millilitre(s)

Manufactured Item

Dose form: Cutaneous spray, solution

Unit of presentation: vial

Ingredient

Role: Active

Substance: Lidocaine

Concentration strength: 100 milligram(s) / 1 millilitre(s)

Reference strength:
Lidocaine 100 milligram(s) / 1 millilitre(s)

Administrable Product (1 of 1)

Dose form: Cutaneous spray, solution

Unit of presentation:

Route of administration:

  • Cutaneous use

Ingredients:

Ingredient

Role: Active

Substance: Lidocaine

Concentration strength: 100 milligram(s) / 1 millilitre(s)

Reference strength:
Lidocaine 100 milligram(s) / 1 millilitre(s)